Document is current
Any future updates will be listed below
-
Authors
Munguía, Lucero
Granero, Roser
Supit, Kim
Lucas, Ignacio
Gearhardt, Ashley N.
Jiménez-Murcia, Susana
Fernández-Aranda, Fernando
-
Funding
Funding for this research was provided by:
Catalan Institution for Research and Advanced Studies (ICREA-Academia, 2021- Programme)
Catalan Institution for Research and Advanced Studies (ICREA-Academia, 2024- Programme)
Ministerio de Ciencia e Innovación (PDI2021-124887OB-I00)
Instituto de Salud Carlos III (FIS22053 – Ref: DTS22/00072)
European Union (eprObes project (GA 101080219))
- License Information
-
More Information
Article History
Received: 30 July 2025
Accepted: 1 December 2025
First Online: 8 December 2025
Declarations
:
: The present study was approved by the Clinical Research Ethics Committee of the Bellvitge University Hospital (Ref. PR146714; PR205/17; PR319/20). According to the Declaration of Helsinki, signed informed consent to participate in the study was obtained from both, control and clinical groups, before completing the assessment. Participants did not receive any form of compensation for their participation in this study.
: FFA and SJM received consultancy honoraria from Novo Nordisk. The rest of the authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
